Use of various offset settings in the Fenwal Amicus during hematopoietic progenitor cell collection to increase lymphocyte yield and reduce cross-cellular contamination

Journal of Clinical Apheresis

Volumn 25, Issue 6, 2010, Pages 301-309

  Burgstaler, Edwin A ^a   Porrata, Luis F ^a   Markovic, Svetomir N ^a   Winters, Jeffrey L ^a  

^a MAYO CLINIC   (United States)

Author keywords

granulocytes; multiple myeloma; Non Hodgkin lymphoma; PBSC; platelets; RBC

Indexed keywords

ADULT; ARTICLE; CD34 SELECTION; CONTAMINATION; CONTROLLED STUDY; ERYTHROCYTE; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HUMAN; LEUKOCYTE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PROCESS OPTIMIZATION; PROSPECTIVE STUDY; THROMBOCYTE;

ANTIGENS, CD34; BLOOD COMPONENT REMOVAL; CELL SEPARATION; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOCYTES;

EID: 78650119781     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20259     Document Type: Article

References (20)

1. Calmels B, Lemarie C, Esterni B, Malugani C, Charbonnier A, Coso D, Schiano de Colella JM, Deconinck E, Caillot D, Viret F, Ladaique P, Lapierre V, Chabannon C,. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product. Transfusion 2007; 47: 1268-1275.
2. Milone G, Mercurio S, Strano A, Leotta S, Pinto V, Battiato K, Coppoletta S, Murgano P, Farsaci B, Privitera A, Giustolisi R,. Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and on patient age. Cytotherapy 2007; 9: 348-355.
3. Bojanic I, Golubic Ceplic B, Mazies, Batinic D, Nemet D, Labar B,. Toxicity related to autologous peripheral blood haemtopoietic progenitor cell infusion is associated with number of granulocytes in graft, gender, and diagnosis of multiple myeloma. Vox Sanguinis 2008; 95: 70-75.
4. Burgstaler EA, Pineda AA, Winters JL,. Hematopoietic progenitor cell large volume leukapheresis (LVL) on Fenwal Amicus blood separator. J Clin Apheresis 2004; 19: 103-111.
5. Snyder EL, Baril L, Cooper DL, Min K, Mechanic S, Stoddart L, Burtness B, Seagraves P, Debelak J, Gudino M, McCullough J,. In vitro collection and post-transfusion engraftment characteristics of MNCs obtained by using a new separator for autologous PBPC transplantation. Transfusion 2000; 40: 961-967.
6. Katipamula R,., Porrata LF, Gastineau DA, Markovic SN, Moore SB, Greiner C, Burgstaler EA, Padley DJ, Winters JL,. Apheresis instrument settings influence infused absolute lymphocyte count affecting survival following autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma: the need to optimize instrument setting and define a lymphocyte collection target. Bone Marrow Transplant 2006; 37: 811-817.
7. Porrata LF, Litzow MR, Inwards DJ, Gastineau DA, Moore SB, Pineda AA, Bundy KL, Padley DJ, Persky D, Ansell SM, Micallef IN, Markovic SN,. Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma. Bone Marrow Transplant 2004; 33: 291-298. (Pubitemid 38256560)
8. Porrata LF, Gertz MA, Geyer SM, Litzow MR, Gastineau DA, Moore SB, Pineda AA, Bundy KL, Padley DJ, Persky D, Lacy MQ, Dispenzieri A, Snow DS, Markovic SN,. The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma. Leukemia 2004; 18: 1085: 1092.
9. Symeonidis A, Ings S, Rabin N, Watts M, D'Sa S, Linch D, Yong K,. Patients with multiple myeloma transplanted with lymphocyte-rich peripheral blood autograft have more favorable outcome. Haematological 2007; 92: 190.
10. Hiwase DK, Hiwase S, Bailey M, Bollard G, Schwarer AP,. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant 2008; 14: 116-124.
11. Burgstaler EA, Pineda AA,. The negative effect of high peripheral white blood cell count on CD34+ cell recovery. J Clin Apheresis 2002; 17: 148.
12. Burgstaler EA, Pineda AA, Winters JL,. Effects of high whole blood flow rates and high peripheral white blood cell counts on CD34+ yield and cross-cellular contamination. Cytotherapy 2003; 5: 446.
13. Ferrara JLM, Deeg HJ,. Graft-versus-host disease. N Engl J Med 1991; 324: 667-674.
14. Iori AP, Torelli GF, DePropris MS, Milano F, Pupella S, Gozzer M, Mancini F, Milani ML, Intoppa S, Cerretti R, Lucarelli B, Valle V, Malandruccolo L, Iannella E, Arleo E, Guarini A, Fia R,. B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation. Transplantation 2008; 85: 386-390.
15. Kernan NA, Collins NH, Juliano L, Cartagena T, Dupont B, O'Reilly RJ,. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood 1986; 68: 770-773.
16. Witt V, Beiglbock E, Ritter R, Würth M, Peters C, Ladenstein R, Gadner H, Fritsch G,. Performance of a new separator system for routine autologous hematopoietic progenitor cell collection in small children. J Clin Apheresis 2007; 22: 306-313.
17. Ikeda K, Ohto H, Kanno T, Ogata T, Noji H, Ogawa K, Maruyama Y,. Automated programs for collection of mononuclear cells and progenitor cells by two separators for peripheral blood progenitor cell transplantation: comparison by a randomized crossover study. Transfusion 2007; 47: 1234-1240.
18. Ikeda K, Ohto H, Nemoto K, Yamamoto G, Kato K, Ogata T, Shichishima T, Maruyama Y,. Collection of MNCs and progenitor cells by two separators for PBSC transplantation: a randomized crossover trial. Transfusion 2003; 43: 814-819.
19. Moog R,. Harvesting of CD34 antigen-expressing cells with a new programme for the collection of mononuclear cells with use of the Amicus (Baxter) blood cell separator. Transfusion Med 2002; 12: 367-371.
20. Snyder EL, O'Donnell L, Dengler TJ, Pomper GJ, Velleca MA, Dincecco DM, Baril LL, Min K, Gudino MD, Bender JR,. Exvivo evaluation of PBMNCs collected with a new separator. Transfusion 2001; 41: 940-949.